Professor Bauersachs acts as Head of the Department of Cardiology and Angiology at Hannover Medical School (MHH). He is Fellow of the American Heart Association, Fellow of the European Society of Cardiology (ESC), Fellow of the Heart Failure Association (HFA) of the ESC, Chair of the HFA Committee on Peripartum Cardiomyopathies (PPCM), and Co-Chair of the worldwide EORP Registry on PPCM. Professor Bauersachs is an interventional cardiologist with special interests in acute coronary syndromes, left ventricular healing and remodelling, acute and chronic heart failure, as well as intensive care. He is particularly interested in the pathophysiology and treatment of PPCM, in aldosterone and mineralocorticoid receptor-mediated mechanisms, and in the role of non-coding RNAs. Professor Bauersachs is Speaker of the Clinical Research Group (KFO) 311 “(Pre-) terminal heart and lung failure – mechanical unloading and repair” funded by the Deutsche Forschungsgemeinschaft (DFG). He is Principal Investigator of HF-REVERT (Phase 2 study to assess the microRNA inhibitor CDR132L in patients after myocardial infarction). Professor Bauersachs is Study Chair of the DIGIT-HF study investigating the effect of Digitoxin on morbidity/mortality in patients with advanced heart failure and is extensively involved in many other clinical trials.

“Cardiovascular disease is the number one cause of death. We need better and faster methods for cardiac drug discovery and development. With my strong background in translational and clinical research in cardiovascular disease I want to help pushing forward the exciting models of human cardiac organoids.”